Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$435M |
| 2 |
Walt Disney
DIS
|
+$434M |
| 3 |
Align Technology
ALGN
|
+$429M |
| 4 |
Icon
ICLR
|
+$371M |
| 5 |
Freeport-McMoran
FCX
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.03B |
| 2 |
Amazon
AMZN
|
+$668M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$420M |
| 4 |
Microsoft
MSFT
|
+$392M |
| 5 |
Aon
AON
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.67% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 10.92% |
| 4 | Financials | 10.29% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Idexx Laboratories
IDXX
$44.9B
| $21.6M | 0.01% |
34,660
-6,127
| -15% | -$4.12M |
|
|
ABCM
777
DELISTED
Abcam PLC
ABCM
| $21.1M | 0.01% |
1,041,353
+42,371
| +4% | +$843K |
|
778
Duke Energy
DUK
$101B
| $21.1M | 0.01% |
215,769
+55,461
| +35% | +$5.74M |
|
779
Fox Class A
FOXA
$24.8B
| $21M | 0.01% |
524,155
-287,739
| -35% | -$10.6M |
|
780
Cogent Biosciences
COGT
$6.76B
| $21M | 0.01% |
2,493,961
+55,760
| +2% | +$427K |
|
781
US Bancorp
USB
$97.9B
| $21M | 0.01% |
352,940
-121,657
| -26% | -$6.93M |
|
782
Franklin FTSE Japan ETF
FLJP
$3.86B
| $21M | 0.01% |
678,736
+82,633
| +14% | +$2.52M |
|
|
NVO
783
Novo Nordisk
NVO
$228B
| $20.9M | 0.01% |
436,292
+9,256
| +2% | +$447K |
|
784
Marqeta
MQ
$1.93B
| $20.9M | 0.01% |
236,688
-163,298
| -41% | -$17.5M |
|
785
Weyerhaeuser
WY
$17.6B
| $20.8M | 0.01% |
585,231
+266,007
| +83% | +$9.32M |
|
|
AMK
786
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $20.8M | 0.01% |
836,200
-6,125
| -0.7% | -$158K |
|
|
SKX
787
DELISTED
Skechers
SKX
| $20.7M | 0.01% |
491,258
+168,059
| +52% | +$8.31M |
|
788
Axogen
AXGN
$2.2B
| $20.6M | 0.01% |
1,305,376
-8,796
| -0.7% | -$158K |
|
|
CADE
789
DELISTED
Cadence Bank
CADE
| $20.5M | 0.01% |
+689,739
| New | +$19.2M |
|
790
SLB Ltd
SLB
$72.7B
| $20.5M | 0.01% |
691,927
-89,076
| -11% | -$2.55M |
|
|
RAIN
791
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $20.5M | 0.01% |
1,402,074
-50,541
| -3% | -$862K |
|
792
TJX Companies
TJX
$179B
| $20.3M | 0.01% |
308,034
+4,478
| +1% | +$313K |
|
793
Manchester United
MANU
$4.03B
| $20.3M | 0.01% |
1,046,840
-9,970
| -0.9% | -$168K |
|
|
PPLI
794
People Inc
PPLI
$3.12B
| $20.2M | 0.01% |
189,197
-30,088
| -14% | -$3.32M |
|
|
TIG
795
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $20.1M | 0.01% |
1,940,493
+743,949
| +62% | +$8.84M |
|
796
Equifax
EFX
$22B
| $20M | 0.01% |
78,826
-3,724
| -5% | -$968K |
|
|
SRDX
797
DELISTED
Surmodics
SRDX
| $19.9M | 0.01% |
358,424
-1,557
| -0.4% | -$86.5K |
|
|
KALV
798
DELISTED
KalVista Pharmaceuticals
KALV
| $19.9M | 0.01% |
1,141,683
-27,917
| -2% | -$566K |
|
799
AST SpaceMobile
ASTS
$15.8B
| $19.8M | 0.01% |
1,832,761
-297
| -0% | -$3.33K |
|
800
Anika Therapeutics
ANIK
$215M
| $19.7M | 0.01% |
463,785
+259,147
| +127% | +$10.7M |
|
Similar funds
Janus Henderson Group's Q3 2021 Portfolio in Review
As of Q3 2021, Janus Henderson Group held 2,257 positions worth $229B, down 2.1% from $234B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q3 2021 filing shows 655 new, 648 increased, 806 reduced and 67 closed positions. Its largest new stake was Ryan Specialty Holdings: 6,061,166 shares worth $205M. The largest sale was Meta Platforms (Facebook), an estimated $1.03B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q3 2021 buy was Ryan Specialty Holdings: 6,061,166 shares worth $205M.
- Janus Henderson Group added most to Deere & Co in Q3 2021, an estimated $435M increase.
- Janus Henderson Group's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $1.03B.
- Janus Henderson Group fully exited Maxim Integrated Products in Q3 2021, selling an estimated $133M.
- Janus Henderson Group's ten largest holdings make up 23% of its $229B portfolio in Q3 2021.
- Janus Henderson Group opened 655 new positions and closed 67 in Q3 2021.
- Janus Henderson Group's portfolio value fell 2.1% quarter-over-quarter to $229B.
Based on Janus Henderson Group's 13F filing for Q3 2021, filed 16 Nov 2021.